Results 231 to 240 of about 252,929 (281)

Effectiveness and Safety of Nusinersen and Risdiplam in Spinal Muscular Atrophy: A Systematic Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Spinal Muscular Atrophy (SMA) is a rare genetic disorder marked by progressive muscle weakness and mobility loss. It has a profound physical, emotional and social impact on patients and caregivers, requiring comprehensive medical and supportive care.
Amin Mehrabian, Peter Auguste, Amy Grove, Anna Brown, Janette Parr, Mubarak Patel, Furqan Butt, Jeremiah Donoghue, Mehdi Yousefi, Jo Parsons   +9 more
wiley   +1 more source

A Systematic Review and Meta-Analysis Investigating the Efficacy of Various Psychedelic Drugs for the Treatment of Substance Use Disorder. [PDF]

Healthcare (Basel)
Keighley EE, Abo Hamza E, Bedewy DA, Nalla S, Moustafa AA.   +4 more
europepmc   +1 more source

Evaluation of the Efficacy and Safety of Satralizumab in a Pregnant NMOSD Patient With AQP4/MOG‐IgG Dual Seropositive: A Case Report

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Neuromyelitis Optica Spectrum Disorder (NMOSD) is a chronic autoimmune neuroinflammatory disease, typically characterized by antibodies against aquaporin 4 (AQP4‐IgG) or myelin oligodendrocyte glycoprotein (MOG‐IgG). Simultaneous seropositivity for both antibodies in a single patient is exceedingly rare.
Yeting Luo, Shuhua Xie, Xianghong Liu
wiley   +1 more source

Heart transplant outcomes in patients with substance use disorder history: a nationwide cohort study using high-dimensional propensity score matching. [PDF]

Eur Heart J Qual Care Clin Outcomes
Elkrief K, Lavin P, Greenway KT, Tate SD, Hussain F, Pike CW, Trepanier A, Hui G, Lespérance P, Kudrina I, Dubreucq S, Ostacher MJ, Jutras-Aswad D, Lembke A, Garel N.   +14 more
europepmc   +1 more source

Substance Use Disorders Among Young People Living with HIV in Sub-Saharan Africa: Insights from a Cohort Study in Ghana

Joseph Ikekwere, Rodney Eiger, Brady J. Heward, Ruth Antwi, Vivien Ugwu, Olasumbo E. Fagbenle, Ajibola Abdulrahamon Ishola, Anthony Enimil, John‐Paul Omuojine, Charles Dickens, Oluwole Jegede, Adeolu Oladunjoye, Dennis Bosomtwe, Ikponmwosa Jude Ogieuhi, Victory Aghogho Emojevwe, Adetola Babalola, Victor Oluwatomiwa Ajekiigbe   +16 more
openalex   +2 more sources

Lessons Learned From a Delayed‐Start Trial of Modafinil for Freezing of Gait in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Freezing of gait (FOG) in people with Parkinson's disease (PwPD) is debilitating and has limited treatments. Modafinil modulates beta/gamma band activity in the pedunculopontine nucleus (PPN), like PPN deep brain stimulation. We therefore tested the hypothesis that Modafinil would improve FOG in PwPD.
Tuhin Virmani, Lakshmi Pillai, Reid D. Landes, Aliyah Glover, Shannon Doerhoff, Jennifer Kleiner, Mitesh Lotia, Rohit Dhall, Edgar Garcia‐Rill   +8 more
wiley   +1 more source

Compounding risks of chronic health conditions and substance use disorder on healthcare burden in the USA: Analysis of NSDUH data (2021-2023). [PDF]

Addict Behav Rep
Iyanda A, Adeleke R, Iyanda O.
europepmc   +1 more source

Predicting Epileptogenic Tubers in Patients With Tuberous Sclerosis Complex Using a Fusion Model Integrating Lesion Network Mapping and Machine Learning

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Accurate localization of epileptogenic tubers (ETs) in patients with tuberous sclerosis complex (TSC) is essential but challenging, as these tubers lack distinct pathological or genetic markers to differentiate them from other cortical tubers.
Tinghong Liu, Qi Wang, Suhui Kuang, Dezhi Cao, Ping Ding, Shaohui Zhang, Haihua Wei, Zhirong Wei, Jinshan Xu, Xinyu Huang, Bing Liu, Shuli Liang   +11 more
wiley   +1 more source

Prevalence of mental illness, substance use disorder, and dual diagnosis among adults in custody. [PDF]

Popul Health Metr
Coulter DJ, Pearce LA, Legge M, Young JT, Preen DB, Heffernan E, Jones J, Kinner SA.   +7 more
europepmc   +1 more source